• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FPH
Click for more information
4.30% $38.55

Fisher & Paykel Healthcare Corporation Limited - Announcements

watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
FPH RMD & FPH Announce Settlement of Global Patent LitigationPRICE SENSITIVE
FPH FPH Confirms no Material Impact on Earnings GuidancePRICE SENSITIVE
FPH Record Result for FPH: Net Profit Up 20%PRICE SENSITIVE
FPH FPH Contests Patent Allegations, Updates Earnings GuidancePRICE SENSITIVE
FPH FPH Upgrades Earnings GuidancePRICE SENSITIVE
FPH 18.08.23 FPH Upgrades Earnings Guidance at ASMPRICE SENSITIVE
FPH 18.08.23 FPH Uprades Earnings Guidance at ASMPRICE SENSITIVE
FPH 18.08.23 FPH Updates Earnings Guidance at ASMPRICE SENSITIVE
FPH Fisher & Paykel Healthcare Reports Record Full Year ResultPRICE SENSITIVE
FPH Strong Half Year Result from FPH Record Net Profit NZ$81.3MPRICE SENSITIVE
FPH 17.08.24 FPH Updates Earnings Guidance at ASMPRICE SENSITIVE
FPH FPH Reports Record Annual Result, Net Profit Up 18%PRICE SENSITIVE
FPH Withdrawal of US ITC Complaint Against FPHPRICE SENSITIVE
FPH FPH Presentation to Deutsche Bank NZ Corporate DayPRICE SENSITIVE
FPH RECORD HALF YEAR RESULT FOR FPH, EARNINGS GUIDANCE UPGRADEDPRICE SENSITIVE
FPH RMD & FPH Announce Settlement of Global Patent Litigation
21/02/19PRICE SENSITIVE
FPH FPH Confirms no Material Impact on Earnings Guidance
21/02/19PRICE SENSITIVE
FPH Record Result for FPH: Net Profit Up 20%
26/11/18PRICE SENSITIVE
FPH FPH Contests Patent Allegations, Updates Earnings Guidance
03/09/18PRICE SENSITIVE
FPH FPH Upgrades Earnings Guidance
23/08/18PRICE SENSITIVE
FPH 18.08.23 FPH Upgrades Earnings Guidance at ASM
23/08/18PRICE SENSITIVE
FPH 18.08.23 FPH Uprades Earnings Guidance at ASM
23/08/18PRICE SENSITIVE
FPH 18.08.23 FPH Updates Earnings Guidance at ASM
23/08/18PRICE SENSITIVE
FPH Fisher & Paykel Healthcare Reports Record Full Year Result
28/05/18PRICE SENSITIVE
FPH Strong Half Year Result from FPH Record Net Profit NZ$81.3M
21/11/17PRICE SENSITIVE
FPH 17.08.24 FPH Updates Earnings Guidance at ASM
24/08/17PRICE SENSITIVE
FPH FPH Reports Record Annual Result, Net Profit Up 18%
22/05/17PRICE SENSITIVE
FPH Withdrawal of US ITC Complaint Against FPH
17/05/17PRICE SENSITIVE
FPH FPH Presentation to Deutsche Bank NZ Corporate Day
08/03/17PRICE SENSITIVE
FPH RECORD HALF YEAR RESULT FOR FPH, EARNINGS GUIDANCE UPGRADED
22/11/16PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
$38.55 		Change
1.590(4.30%) 		Mkt cap ! n/a
Open High Low Value Volume
$37.00 $38.85 $36.86 $23.56M 613.3K

Buyers (Bids)

No. Vol. Price($)
0 3648 $38.06
 

Sellers (Offers)

Price($) Vol. No.
$38.62 1 0
Last trade - 13.00pm 22/11/2024 (20 minute delay) ?
FPH (NZSX) Chart

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.